Impact of a Nurse Navigator on Genomic Testing and Timely Treatment Decision Making in Patients With Breast Cancer

Kelly A. McAllister, RN, BSN, OCN, CBCN; Mary L. Schmitt, MS, APRN, FNP-BC, AOCNP

Disclosures

Clin J Oncol Nurs. 2015;19(5):510-512. 

In This Article

Aim of the Project

The aim of this project was to develop a timely, evidence-based process for the use of Oncotype DX test results to enhance decision making for women with early-stage, ER+, HER2/neu-negative breast cancer. The measures of success of this project were to (a) improve the turnaround time for ordering Oncotype DX, (b) improve the turnaround time for reporting results, and (c) comply with the NCCN recommendations to test eligible patients.

Ordering turnaround time was defined as the average number of days from surgery to the date the test is ordered. Reporting turnaround time was defined as the average number of days from surgery to the date the test result was reported.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....